Results 291 to 300 of about 1,479,889 (356)

Proteomic signatures of type 2 diabetes predict the incidence of coronary heart disease. [PDF]

Cardiovasc Diabetol
Li Y, Li D, Lin J, Zhou L, Yang W, Yin X, Xu C, Cao Z, Wang Y.   +8 more
europepmc   +1 more source

Predicting coronary heart disease with advanced machine learning classifiers for improved cardiovascular risk assessment. [PDF]

Sci Rep
Rehman MU, Naseem S, Butt AUR, Mahmood T, Khan AR, Khan I, Khan J, Jung Y.   +7 more
europepmc   +1 more source

Polygenic prediction of coronary heart disease among 130,000 Mexican adults

Liu T, Berumen J, Torres J, Alegre-Díaz J, Baca P, González-Carballo C, Ramirez-Reyes R, Rivas F, Aguilar-Ramirez D, Bragg F, Herrington W, Hill M, Trichia E, Vergara A, Wade R, Collins R, Kuri-Morales P, Emberson J, Tapia-Conyer R, Friedrichs LG.   +19 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham study.

Annals of Internal Medicine, 2020
Risk of coronary heart disease over 14 years was examined prospectively in 2,282 men and 2,845 women according to their antecedent cholesterol and lipoprotein status.
W. Kannel, W. Castelli, T. Gordon, P. McNamara   +3 more
semanticscholar   +1 more source

Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease.

New England Journal of Medicine, 1987
In a randomized, double-blind five-year trial, we tested the efficacy of simultaneously elevating serum levels of high-density lipoprotein (HDL) cholesterol and lowering levels of non-HDL cholesterol with gemfibrozil in reducing the risk of coronary ...
M. Frick, Olli Elo, K. Haapa, O. Heinonen, P. Heinsalmi, Pekka Helo, J. Huttunen, P. Kaitaniemi, P. Koskinen, V. Manninen, H. Mäenpää, M. Mälkönen, M. Mänttäri, S. Norola, A. Pasternack, J. Pikkarainen, M. Romo, T. Sjöblom, E. Nikkilä   +18 more
semanticscholar   +1 more source

Folate and coronary heart disease

Current Opinion in Lipidology, 1998
Low folate intake is an important determinant of elevated blood levels of homocysteine. Because elevated homocysteine has been shown to be a possible graded risk factor for CHD, sufficient folate intake may be important in the prevention of CHD. The magnitude of the association between folate and CHD is consistent with its effects on homocysteine.
Verhoef, P., Stampfer, M.J., Rimm, E.B.
openaire   +4 more sources

Coronary Heart Disease

2008
Coronary heart disease (CHD) is the most common cause of death worldwide. Mortality from CHD increases with advancing age, and age-adjusted CHD rates are higher in men compared to women. There is a large regional variation in coronary mortality both within and between countries.
Jacqueline Müller-Nordhorn, Stefan N. Willich   +1 more
openaire   +2 more sources

DIET AND CORONARY HEART DISEASE [PDF]

British Medical Bulletin, 1981
There is a moderately good correlation between dietary saturated fatty acids and coronary heart disease (CHD) when populations in different parts of the world are compared but not within the same cultural community or for individuals. Total energy, essential fatty acids (EFA), dietary fibre, alcohol and salt also contribute to the relationship of diet ...
openaire   +3 more sources

Periodontal Disease and Coronary Heart Disease

Journal of Periodontology, 2006
Background: Several epidemiological studies have demonstrated an association between periodontal disease and coronary heart disease (CHD). The association could be a result of confounding by mutual risk factors. The present study was undertaken in a Danish population to reveal the significance of common risk factors.Methods: The investigation was ...
Geismar, K., Stoltze, K., Sigurd, B., Gyntelberg, Finn, Holmstrup, Palle   +4 more
openaire   +3 more sources